Telix Pharmaceuticals Limited (TLX)

Telix Pharmaceuticals Revenue

In the year 2024, Telix Pharmaceuticals had annual revenue of 783.21M AUD with 55.85% growth. Telix Pharmaceuticals had revenue of 209.62M in the quarter ending December 31, 2024, with 48.82% growth.

• Revenue (ttm): 783.21M AUD
• Revenue Growth: +55.85%
• P/S Ratio: 10.98
• Revenue / Employee: 1,887,246 AUD
• Employees: 415
• Market Cap: 5.32B undefined

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	783.21M	280.66M	55.85%
Dec 31, 2023	502.55M	342.45M	213.90%
Dec 31, 2022	160.10M	152.50M	2,007.64%
Dec 31, 2021	7.60M	2.38M	45.71%
Dec 31, 2020	5.21M	1.73M	49.58%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.